CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Press Trust of India dated 20th December 2022. Press Trust of India.
![[img]](https://eprints.cmfri.org.in/style/images/fileicons/text.png) |
Text
Press Trust of India_21-12-2022.pdf Download (24kB) |
Official URL: https://www.ptinews.com/news/south/cmfri-signs-mou...
Abstract
The Central Marine Fisheries Research Institute (CMFRI) has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD).
| Item Type: | Article |
|---|---|
| Subjects: | CMFRI News Clippings |
| Divisions: | Library and Documentation Centre |
| Depositing User: | Mr. Augustine Sipson N A |
| Date Deposited: | 26 Dec 2022 04:33 |
| Last Modified: | 26 Dec 2022 04:33 |
| URI: | http://eprints.cmfri.org.in/id/eprint/16550 |
Actions (login required)
 |
View Item |
